CLINICAL AND PHARMACOLOGICAL EVALUATION OF THE INFLUENCE OF DIFFERENT CLINICAL FACTORS ON THE DETERMINED LEVEL OF GLYCATED HEMOGLOBIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2 (26-31)

DOI: 10.31618/ESU.2413-9335.2020.3.73.664

Дата публикации статьи в журнале: 2020/05/12

Название журнала: Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале, Выпуск: 73, Том: 3, Страницы в выпуске: 26-31

Автор: Moroz V.A.
Doctor of Med.Sci., Professor , University of Pharmacy,

Автор: Tymchenko Yu.V.
Candidate of Med.Sci., Associate Professor , University of Pharmacy,

Автор: Semenov A.M.
Candidate of Med.Sci., Associate Professor , University of Pharmacy,

Анотация: With the purpose to determine the prevalence and significance of the influence of various clinical factors on the glycemic control of patients with diabetes mellitus type II, 118 case histories of a therapeutic hospital were analyzed. Analysis of the documentation included the identification of concomitant diseases and conditions, as well as the use of medicines that could directly or indirectly affect the level of HbA1c detected in the patient's blood. In the first case, the presence of such a pathology or condition was revealed in 35 patients (29.7% of the contingent). Moreover, in the 22s they influenced the direction of false understatement, and in 13, on the contrary, its false overestimation. Acceptance of medicines that had significant potential for falsification of the determined level of HbA1c was observed in 39 patients (33.1% of the examined). The quantitative values of the possible analysis error as a result of such influences are discussed. The need for a more thorough analysis of the upcoming course of medicinal therapy for patients with diabetes mellitus type II, including with the participation of a clinical pharmacist (pharmacologist), is indicated.

Ключевые слова: diabetes mellitus, glycated hemoglobin,glycemic control,iron deficiency anemia,chronic blood loss,hypercholesterolemia,hemoglobinopathies,

Данные для цитирования: Moroz V.A. Tymchenko Yu.V. Semenov A.M. . CLINICAL AND PHARMACOLOGICAL EVALUATION OF THE INFLUENCE OF DIFFERENT CLINICAL FACTORS ON THE DETERMINED LEVEL OF GLYCATED HEMOGLOBIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2 (26-31) // Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале. Медицинские науки. 2020/05/12; 73(3):26-31. 10.31618/ESU.2413-9335.2020.3.73.664

Скачать в формате PDF

Список литературы: 1. Identifying Trends in Undiagnosed Diabetes in U.S. Adults by Using a Confirmatory Definition A Cross-Sectional Study / E. Selvin, D. Wang, A.K. Lee [et al.] // Ann Intern Med. 2017; 167(11): 769-776. doi:10.7326/M17-1272 2. Undiagnosed Diabetes Mellitus and Related Factors in East Gojjam (NW Ethiopia) in 2016: A Community-Based Study / A.T. Wondemagegn, H.M. Bizuayehu, D.D. Abie [et al.] // J Public Health Res. 2017; 6(1): 834. doi: 10.4081/jphr.2017.834. 3. Prevalence of Diagnosed Diabetes in Adults by Diabetes Type – United States, 2016 / K.M. Bullard, C.C. Cowie, S.E. Lessem [et al.] // MMWR Morb Mortal Wkly Rep. 2018; 67(12): 359-361. doi: 10.15585/mmwr.mm6712a2. 4. IDF Diabetes Atlas. 7th ed. - Brussels: IDF, 2015.- 144 p. 5. Moroz V.A. Clinical and pharmaceutical analysis features of oral hypoglycemic medications usage at patients with diabetes mellitus type 2 / V.A. Moroz, E.F. Grintsov // Eksperymentalna i klinichna medytsyna. 2016; 1(70): 52-58. 6. American Diabetes Association Diagnosis and classification of diabetes mellitus // Diabetes Care. 2012; 35(Suppl 1): S64-S71. doi: 10.2337/dc12-s064. 7. Li R. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review / R. Li, P. Zhang, L.E. Barker, F.M. Chowdhury, X. Zhang // Diabetes Care 2010; 33: 1872-1894. doi: 10.2337/dc10-0843. 8. International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes // Diabetes Care 2009; 32: 1327-1334. doi: 10.2337/dc09-9033. 9. George J.A. Haemoglobin A1c or Glycated Albumin for Diagnosis and Monitoring Diabetes: An African Perspective / J.A. George, R.T. Erasmus // Indian J Clin Biochem. 2018; 33(3): 255-261. doi: 10.1007/s12291-018-0755-9. 10. Ciaccio M. Introduction of glycated albumin in clinical practice / M. Ciaccio // J Lab Precis Med 2019; 4: 28. doi: 10.21037/jlpm.2019.08.02. 11. Jain R.C. Sickle cell and thalassaemic genes in Libya / R.C. Jain // Trans R Soc Trop Med Hyg. 1985; 79(1): 132-3. doi: 10.1016/0035-9203(85)90257-3. 12. Klonoff D.C. Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus / D.C. Klonoff // J Diabetes Sci Technol. 2020; 14(1): 3-7. doi: 10.1177/1932296819841698. 13. Schiavon L.L. HbA1c Levels as a Parameter of Glycemic Control in Patients with Liver Diseases / L.L. Schiavon, J.L. Narciso-Schiavon // Annals of Hepatology, 2017; 16 (3): 469-470. doi: 10.5604/16652681.1235495 14. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes? / E. Orsi, V. Grancini, S. Menini [et al.] // Liver Int. 2017; 37(7): 950-962. doi: 10.1111/liv.13337. 15. Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study / S.H. Alzahrani, M. Baig, M.M. Aashi [et al.] // Diabetes Metab Syndr Obes. 2019; 12: 1639-1644. doi: 10.2147/DMSO.S222271. 16. Radin M.S. Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading / M.S. Radin // J Gen Intern Med. 2014; 29(2): 388-394. doi: 10.1007/s11606-013-2595-x. 17. Increased plasma malondialdehyde and fructosamine in iron deficiency anemia: effect of treatment / R.C. Sundaram, N. Selvaraj, G. Vijayan [et al.] // Biomed Pharmacother 2007; 61: 682-5. doi: 10.1016/j.biopha.2007.06.013/ 18. Welsh K.J. Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions / K.J. Welsh, M.S. Kirkman, D.B. Sacks // Diabetes Care 2016; 39: 1299-306. doi: 10.2337/dc15-2727. 19. The Relationship Between Alcohol Consumption and Glycemic Control Among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry / A.T. Ahmed, A.J. Karter, E.M. Warton [et al.] // J Gen Intern Med. 2008; 23(3): 275-282. doi: 10.1007/s11606-007-0502-z. 20. Hong J.W. Association between Alcohol Intake and Hemoglobin A1c in the Korean Adults: The 2011-2013 Korea National Health and Nutrition Examination Survey / J.W. Hong, J.H. Noh, D.J. Kim // Plos one 2016; 11(11): e0167210. doi.org/10.1371/journal.pone.0167210. 21. Serum bilirubin is significantly associated with Hba1c in type 2 diabetic subjects / T. Farasat, S. Sharif, F. Manzoor et al. // Endocrinol Metab Int J. 2017; 5(6): 338-341. doi: 10.15406/emij.2017.05.00142. 22. Differential Effects of Azithromycin, Doxycycline, and Cotrimoxazole in Ingested Blood on the Vectorial Capacity of Malaria Mosquitoes / M. Gendrin, R.S. Yerbanga, J.B. Ouedraogo [et al.] // Open Forum Infectious Diseases 2016; 3(2): ofw074. doi.org/10.1093/ofid/ofw074. 23. Cappellini M.D. Glucose-6-phosphate dehydrogenase deficiency / M.D. Cappellini, G. Fiorelli // Lancet. 2008; 371(9606): 64-74. doi: 10.1016/S0140-6736(08)60073-2. 24. Aspirin-mediated acetylation of haemoglobin increases in presence of high glucose concentration and decreases protein glycation / F. Finamore, F. PriegoCapote, S. Nolli [et al.] // EuPA Open Proteomics 2015; 8: 116-127. doi.org/10.1016/j.euprot.2015.04.003. 25. Kotb A. Effect of Vitamin C on Blood Glucose and Glycosylated Hemoglobin in Type II Diabetes Mellitus / A. Kotb, K.M. Al Azzam // World Journal of Analytical Chemistry 2015; 3(1A): 6-8. doi: 10.12691/wjac-3-1A-2.